Examination of the phosphoenolpyruvate carboxykinase gene promoter in patients with noninsulin-dependent diabetes mellitus.

Expression of phosphoenolpyruvate carboxykinase (PEPCK), a rate-limiting enzyme in gluconeogenesis, is under dominant negative regulation by insulin. In this study, we sought to test the hypothesis that mutations in the PEPCK gene promoter may impair the ability of insulin to suppress hepatic glucose production, thereby contributing to both the insulin resistance and increased rate of gluconeogenesis characteristic of NIDDM. The proximal PEPCK promoter region in 117 patients with noninsulin-dependent diabetes mellitus and 20 obese Pima Indians was amplified by PCR and analyzed with single strand conformation polymorphism techniques. In addition, limited direct DNA sequencing was performed on the insulin response sequence and flanking regions. No DNA sequence polymorphisms were found in any patient. This result suggests that mutations in cis-acting PEPCK gene regulatory elements do not constitute a common cause of noninsulin-dependent diabetes mellitus. The significance of genetic variation in promoter regions to human disease is discussed.

[1]  R. O’Brien,et al.  Regulation of gene expression by insulin. , 1991, Physiological reviews.

[2]  F. Bosch,et al.  Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Moller,et al.  Comparative sensitivity of alternative single-strand conformation polymorphism (SSCP) methods. , 1994, BioTechniques.

[4]  Y. Yazaki,et al.  Analysis of the glucokinase gene promoter in Japanese subjects with noninsulin-dependent diabetes mellitus. , 1994, The Journal of clinical endocrinology and metabolism.

[5]  T. Hansen,et al.  Genetic Variants in Promoters and Coding Regions of the Muscle Glycogen Synthase and the Insulin-Responsive GLUT4 Genes in NIDDM , 1994, Diabetes.

[6]  H. Makino,et al.  Islet amyloid polypeptide gene: no evidence of abnormal promoter region in thirty-five type 2 diabetic patients. , 1994, Diabetes research and clinical practice.

[7]  J. Proietto,et al.  Impaired suppression of gluconeogenesis induced by overexpression of a noninsulin-responsive phosphoenolpyruvate carboxykinase gene. , 1993, Molecular endocrinology.

[8]  T. Hongyo,et al.  'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. , 1993, Nucleic acids research.

[9]  D. Levin,et al.  Limitations in the use of SSCP analysis. , 1993, Mutation research.

[10]  V. Sheffield,et al.  The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. , 1993, Genomics.

[11]  D. Cooper,et al.  Regulatory mutations and human genetic disease. , 1992, Annals of medicine.

[12]  M. Balbín,et al.  Demonstration of sequence variations in the promoter region of the human cystatin C gene. , 1992, Biological chemistry Hoppe-Seyler.

[13]  M. Permutt,et al.  Variability of the Insulin Gene in American Blacks With NIDDM: Analysis by Single-Strand Conformational Polymorphisms , 1992, Diabetes.

[14]  A. Consoli.  Role of Liver in Pathophysiology of NIDDM , 1992, Diabetes Care.

[15]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[16]  R. O’Brien,et al.  Signal transduction convergence: phorbol esters and insulin inhibit phosphoenolpyruvate carboxykinase gene transcription through the same 10-base-pair sequence. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. O’Rahilly,et al.  Detection of Mutations in Insulin-Receptor Gene in NIDDM Patients by Analysis of Single-Stranded Conformation Polymorphisms , 1991, Diabetes.

[18]  R. O’Brien,et al.  Complex hormone response unit regulating transcription of the phosphoenolpyruvate carboxykinase gene: from metabolic pathways to molecular biology. , 1991, Recent progress in hormone research.

[19]  R. O’Brien,et al.  Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription. , 1990, Science.

[20]  A. Kessling,et al.  G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. , 1990, Molecular biology & medicine.

[21]  R. O’Brien,et al.  PEPCK Gene as Model of Inhibitory Effects of Insulin on Gene Transcription , 1990, Diabetes Care.

[22]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[23]  L. Groop,et al.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.

[24]  F. Capani,et al.  Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM , 1989, Diabetes.

[25]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Mandarino,et al.  Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. , 1988, Metabolism: clinical and experimental.

[27]  R. Rizza,et al.  Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity. , 1987, Metabolism: clinical and experimental.

[28]  A. Wynshaw-Boris,et al.  Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. II. Identification of cAMP and glucocorticoid regulatory domains. , 1986, The Journal of biological chemistry.

[29]  A. Wynshaw-Boris,et al.  Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. I. Multiple hormone regulatory elements and the effects of enhancers. , 1986, The Journal of biological chemistry.

[30]  R. Dernick,et al.  Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining , 1985 .

[31]  D. Granner,et al.  Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. , 1984, The Journal of biological chemistry.

[32]  D. Granner,et al.  Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin , 1983, Nature.

[33]  W. Lamers,et al.  cAMP stimulates transcription of the gene for cytosolic phosphoenolpyruvate carboxykinase in rat liver nuclei. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[34]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Hanson,et al.  Purification of phosphoenolpyruvate carboxykinase from the cytosol fraction of rat liver and the immunochemical demonstration of differences between this enzyme and the mitochondrial phosphoenolpyruvate carboxykinase. , 1969, Journal of Biological Chemistry.